[1]
2023. Removing the Roadblocks in Equitable Global Access to COVID-19 Vaccine through IPR Waiver. Journal of Intellectual Property Rights (JIPR). 27, 3 (Jul. 2023), 163–170. DOI:https://doi.org/10.56042/jipr.v27i3.64890.